Cancers · 2024 · 12 citations · 121 references
Life SciencesGeneticsPediatricsGenomicsPediatric GeneticsPediatric OncologyCancer GenomicsClinical GenomicsGermline Cancer PredispositionGermline Cancer SusceptibilityHereditary Cancer SyndromesNewborn Genetic ScreeningCancer Screening StrategiesGermline Cancer Predisposition SyndromesGermline PredispositionNewborn Genomic ScreeningNewborn ScreeningNewborn Screening For Genetic DisordersPediatric Cancer PrevalencePediatric Tumor Predisposition Syndromes
As next-generation sequencing (NGS) has become more widely used, germline and rare genetic variations responsible for inherited illnesses, including cancer predisposition syndromes (CPSs) that account for up to 10% of childhood malignancies, have been found. The CPSs are a group of germline genetic disorders that have been identified as risk factors for pediatric cancer development. Excluding a few "classic" CPSs, there is no agreement regarding when and how to conduct germline genetic diagnostic studies in children with cancer due to the constant evolution of knowledge in NGS technologies. Various clinical screening tools have been suggested to aid in the identification of individuals who are at greater risk, using diverse strategies and with varied outcomes. We present here an overview of the primary clinical and molecular characteristics of various CPSs and summarize the existing clinical genomics data on the prevalence of CPSs in pediatric cancer patients. Additionally, we discuss several ethical issues, challenges, limitations, cost-effectiveness, and integration of genomic newborn screening for CPSs into a healthcare system. Furthermore, we assess the effectiveness of commonly utilized decision-support tools in identifying patients who may benefit from genetic counseling and/or direct genetic testing. This investigation highlights a tailored and systematic approach utilizing medical newborn screening tools such as the genome sequencing of high-risk newborns for CPSs, which could be a practical and cost-effective strategy in pediatric cancer care.
121
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Stephen Friend, René Bernards, Snezna Rogelj et al. · Nature · 1986 · 3K citations · Full text
Rate of de novo mutations and the importance of father’s age to disease risk
Augustine Kong, Michael L. Frigge, Gísli Másson et al. · Nature · 2012 · 2.3K citations
International incidence of childhood cancer, 2001–10: a population-based registry study
Eva Steliarova‐Foucher, Murielle Colombet, Lynn A. G. Ries et al. · The Lancet Oncology · 2017 · 1.8K citations · Full text
Medicine, Oncology, Pediatrics +17
The landscape of genomic alterations across childhood cancers
Susanne Gröbner, Barbara C. Worst, Joachim Weischenfeldt et al. · Nature · 2018 · 1.6K citations · Full text
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yaping Yang, Donna M. Muzny, Fan Xia et al. · JAMA · 2014 · 1.4K citations